Assessment of Lupus Anticoagulant Positivity in Patients With COVID-19

This cohort study assesses the prevalence of lupus anticoagulant (LA) positivity in patients with coronavirus disease 2019 (COVID-19) and examines the association of LA positivity with patient outcomes.

Read the full article here

Related Articles